| IGF-I (1-3), GPE | C12H19N3O6 | 301.30 | 32302-76-4 | H-Gly-Pro-Glu-OH |
| IGF-I (24-41) | C88H133N27O28 | 2017.19 | 135861-49-3 | H-Tyr-Phe-Asn-Lys-Pro-Thr-Gly-Tyr-Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro-Gln-Thr-OH |
| IGF-I (30-41), IGF-I C-Peptide | C51H83N19O19 | 1266.34 | 82177-09-1 | H-Gly-Tyr-Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro-Gln-Thr-OH |
| IGF-II (33-40), IGF-II C-Peptide | C38H74N20O12 | 1003.13 | 103244-41-3 | H-Ser-Arg-Val-Ser-Arg-Arg-Ser-Arg-OH |
| Lys-Lys-IRS-1 (891-902) (dephosphorylated) (human), Lys-Lys-Insulin Receptor Substrate-1 (891-902) (dephosphorylated) (human), Lys-Lys-IRS-1 (886-897) (dephosphorylated) (mouse), Lys-Lys-IRS-1 (890-901) (dephosphorylated) (rat), IGF1RK Peptide Substrate | C73H114N18O22 | 1595.82 | 172615-51-9 | H-Lys-Lys-Lys-Ser-Pro-Gly-Glu-Tyr-Val-Asn-Ile-Glu-Phe-Gly-OH |
| Insulin B (22-25) | C26H35N7O5 | 525.61 | 34367-73-2 | H-Arg-Gly-Phe-Phe-OH |
| AF12198 | C96H123N19O22 | 1895.15 | 185413-30-3 | Ac-Phe-Glu-Trp-Thr-Pro-Gly-Trp-Tyr-Gln-L-azetidine-2-carbonyl-Tyr-Ala-Leu-Pro-Leu-NH2 |
| IL-1α (223-250) (human) Interleukin-1α (223-250) (human) |
C158H219N37O44 | 3340.70 | H-Phe-Phe-Tyr-Glu-Thr-His-Gly-Thr-Lys-Asn-Tyr-Phe-Thr-Ser-Val-Ala-His-Pro-Asn-Leu-Phe-Ile-Ala-Thr-Lys-Gln-Asp-Tyr-OH | |
| IL-1β (163-171) (human), Interleukin-1β (163-171) (human) | C39H64N12O19 | 1005.01 | 106021-96-9 | H-Val-Gln-Gly-Glu-Glu-Ser-Asn-Asp-Lys-OH |
| IL-1β (178-207) (human) Interleukin-1β (178-207) (human) |
C157H256N38O49S | 3492.05 | H-Leu-Lys-Glu-Lys-Asn-Leu-Tyr-Leu-Ser-Cys-Val-Leu-Lys-Asp-Asp-Lys-Pro-Thr-Leu-Gln-Leu-Glu-Ser-Val-Asp-Pro-Lys-Asn-Tyr-Pro-OH | |
| (D-Pro194)-IL-1β (193-195) (human) (D-Pro194)-Interleukin-1β (193-195) (human), LDPT |
C15H28N4O5 | 344.41 | 117027-34-6 | H-Lys-D-Pro-Thr-OH |
| IL-1β (208-240) (human) Interleukin-1β (208-240) (human) |
C191H292N48O51S | 4108.78 | 130587-39-2 | H-Lys-Lys-Lys-Met-Glu-Lys-Arg-Phe-Val-Phe-Asn-Lys-Ile-Glu-Ile-Asn-Asn-Lys-Leu-Glu-Phe-Glu-Ser-Ala-Gln-Phe-Pro-Asn-Trp-Tyr-Ile-Ser-Thr-OH Trifluoroacetate salt |
| IL-6 (88-121) (human) Interleukin-6 (88-121) (human) |
C179H281N45O58S | 4023.53 | 145990-81-4 | H-Ile-Ile-Thr-Gly-Leu-Leu-Glu-Phe-Glu-Val-Tyr-Leu-Glu-Tyr-Leu-Gln-Asn-Arg-Phe-Glu-Ser-Ser-Glu-Glu-Gln-Ala-Arg-Ala-Val-Gln-Met-Ser-Thr-Lys-OH |
| IL-8 (-5 to +5) | C48H86N14O14 | 1083.30 | H-Ala-Val-Leu-Pro-Arg-Ser-Ala-Lys-Glu-Leu-OH | |
| IL-8 Inhibitor, Antileukinate | C45H66N18O7S | 1003.20 | 138559-60-1 | Ac-Arg-Arg-Trp-Trp-Cys-Arg-NH2 |
| IL-1 Receptor Peptide (human) | C47H88N14O12S | 1073.37 | 141801-03-8 | H-Lys-Ile-Cys-Ile-Arg-Ile-Gln-Ile-Ser-OH |
| IL-8ra (9-29) Interleukin-8 receptor antagonist (9-29) |
C112H150N24O38S2 | 2504.69 | Ac-Met-Trp-Asp-Phe-Asp-Asp-Leu-Asn-Phe-Thr-Gly-Met-Pro-Pro-Ala-Asp-Glu-Asp-Tyr-Ser-Pro-NH2 | |
| AF11377 | C95H122N18O22 | 1868.12 | 171492-13-0 | H-Phe-Glu-Trp-Thr-Pro-Gly-Tyr-Trp-Gln-Pro-Tyr-Ala-Leu-Pro-Leu-OH |
| Intermedin (human), hIMD, IMD (human), Adrenomedullin-2 (human), ADM2 (human) | C219H349N69O66S3 | 5100.80 | H-Thr-Gln-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Met-Gly-Pro-Ala-Gly-Arg-Gln-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH2 (Disulfide bond) | |
| Intermedin (rat) IMD (rat), rIMD, Adrenomedullin-2 (rat), ADM2 (rat) |
C226H361N75O64S2 | 5216.95 | H-Pro-His-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Val-Arg-Pro-Ser-Gly-Arg-Arg-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH2 (Disulfide bond) |
